Determining the molecular profile of adult brainstem gliomas is very important clinically because IDH-mutant diffuse gliomas frequently harbor a methylated MGMT promoter and can be expected to respond to TMZ treatment (11, 25). Here, IDH2 is linked to brain stem glioma.